AbbVie
ABBV
163,66 €
Share price
3.15%
Change (1 day)
4.68%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Total debt
Total debt on the balance sheet as of December 2024 : €59.05 Billion
According to AbbVie's latest financial reports the company's total debt is €59.05 Billion. A company’s total debt is the sum of all current and non-current debts.
AbbVie - Total debt on balance sheet (from 2011 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | €64.52 B | 20.11% |
| 2023-12-31 | €53.71 B | -8.93% |
| 2022-12-31 | €58.98 B | -12.89% |
| 2021-12-31 | €67.71 B | -3.22% |
| 2020-12-31 | €69.96 B | 17.46% |
| 2019-12-31 | €59.56 B | 69.05% |
| 2018-12-31 | €35.23 B | 13.14% |
| 2017-12-31 | €31.14 B | -11.08% |
| 2016-12-31 | €35.02 B | 20.92% |
| 2015-12-31 | €28.96 B | 135.22% |
| 2014-12-31 | €12.31 B | 15.51% |
| 2013-12-31 | €10.66 B | -10.02% |
| 2012-12-31 | €11.84 B | 31954.69% |
| 2011-12-31 | €36.96 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | €55.98 B | -5.21% | 🇺🇸 USA |
 | €45.03 B | -23.75% | 🇺🇸 USA |
 | €29.59 B | -49.89% | 🇺🇸 USA |
 | €52.86 B | -10.49% | 🇺🇸 USA |
 | €23.49 B | -60.22% | 🇺🇸 USA |
 | €5.83 B | -90.13% | 🇺🇸 USA |
 | €18.74 B | -68.25% | 🇬🇧 UK |
 | €26.48 B | -55.15% | 🇬🇧 UK |
 | €0.40 B | -99.32% | 🇺🇸 USA |